Literature DB >> 21220701

C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.

Toshiyuki Nagai1, Toshihisa Anzai, Hidehiro Kaneko, Yoshinori Mano, Atsushi Anzai, Yuichiro Maekawa, Toshiyuki Takahashi, Tomomi Meguro, Tsutomu Yoshikawa, Keiichi Fukuda.   

Abstract

Serum C-reactive protein (CRP) elevation predicts the development of heart failure in patients with hypertension. CRP activates macrophages and enhances oxidative stress. We hypothesize that CRP itself has a pathogenic role in the development of pressure overload-induced cardiac remodeling. Transgenic mice with human CRP overexpression (CRPtg) and nontransgenic littermates (CON) were subjected to transverse aortic constriction (TAC/CRPtg and TAC/CON) or sham operation (Sham/CRPtg and Sham/CON). One week after operation, in TAC/CRPtg, myocardial mRNA levels of interleukin (IL)-6, CD68, glutathione peroxidase-3 (GPx3), 47-kDa α-subunit of nicotinamide adenine dinucleotide phosphate oxidase (p47(phox)), and collagen-I, the number of infiltrating Mac-2-positive macrophages, nuclear localization of phosphorylated NF-κB/p65 (p-p65) in cardiomyocytes, nuclear NF-κB-DNA-binding activity, and reactive oxygen species (ROS) content were increased compared to those in TAC/CON. Cardiac fibrosis was more prominent in TAC/CRPtg compared to TAC/CON. Four weeks after operation, heart and lung weights, cardiomyocyte cross-sectional area, and the extent of cardiac fibrosis were greater in TAC/CON than in Sham/CON, and these differences were further augmented in TAC/CRPtg compared to TAC/CON. Left ventricular (LV) fractional shortening was less and LV end-diastolic pressure was higher in TAC/CRPtg than in TAC/CON. Myocardial mRNA levels of angiotensin type 1 receptor, atrial natriuretic factor, IL-6, GPx3, p47(phox), collagen-I, and transforming growth factor (TGF)-β1, the protein level of TGF-β1, and the numbers of Mac-2-positive macrophages and p-p65-positive cells were higher in TAC/CRPtg than in TAC/CON. In conclusion, CRP itself may have a pathogenic role in the development of pressure overload-induced cardiac remodeling, possibly through enhanced inflammation and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220701     DOI: 10.1161/HYPERTENSIONAHA.110.158915

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Effects of C-reactive protein on K(+) channel interaction protein 2 in cardiomyocytes.

Authors:  Yong Xie; Jing-Ting Mai; Fei Wang; Yong-Qing Lin; Wo-Liang Yuan; Nian-Sang Luo; Ming-Cheng Fang; Jing-Feng Wang; Yang-Xin Chen
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

2.  Eicosapentaenoic acid suppresses adverse effects of C-reactive protein overexpression on pressure overload-induced cardiac remodeling.

Authors:  Toshiyuki Nagai; Toshihisa Anzai; Yoshinori Mano; Hidehiro Kaneko; Atsushi Anzai; Yasuo Sugano; Yuichiro Maekawa; Toshiyuki Takahashi; Tsutomu Yoshikawa; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2012-08-09       Impact factor: 2.037

3.  Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke: Correlates of Stroke Cause and Recurrence.

Authors:  Heather J Fullerton; Gabrielle A deVeber; Nancy K Hills; Michael M Dowling; Christine K Fox; Mark T Mackay; Adam Kirton; Jerome Y Yager; Timothy J Bernard; Eldad A Hod; Max Wintermark; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-08-04       Impact factor: 7.914

4.  CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.

Authors:  Jia-Hong Wang; Feng Su; Shijun Wang; Xian-Cheng Lu; Shao-Heng Zhang; De Chen; Nan-Nan Chen; Jing-Quan Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling.

Authors:  Husam M Salah; Subodh Verma; Carlos G Santos-Gallego; Ankeet S Bhatt; Muthiah Vaduganathan; Muhammad Shahzeb Khan; Renato D Lopes; Subhi J Al'Aref; Darren K McGuire; Marat Fudim
Journal:  J Cardiovasc Transl Res       Date:  2022-03-15       Impact factor: 4.132

Review 6.  C-reactive protein and hypertension.

Authors:  F G Hage
Journal:  J Hum Hypertens       Date:  2013-11-14       Impact factor: 3.012

7.  Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.

Authors:  Fadia A Kamal; Deanne M Mickelsen; Katherine M Wegman; Joshua G Travers; Jacob Moalem; Stephen R Hammes; Alan V Smrcka; Burns C Blaxall
Journal:  J Am Coll Cardiol       Date:  2014-04-02       Impact factor: 24.094

8.  Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.

Authors:  Ana Barac; Hong Wang; Nawar M Shara; Giovanni de Simone; Elizabeth A Carter; Jason G Umans; Lyle G Best; Jeunliang Yeh; Damon B Dixon; Richard B Devereux; Barbara V Howard; Julio A Panza
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-01       Impact factor: 3.738

9.  Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.

Authors:  Satoshi Suzuki; Tetsuro Shishido; Akira Funayama; Shunsuke Netsu; Mitsunori Ishino; Tatsuro Kitahara; Toshiki Sasaki; Shigehiko Katoh; Yoichiro Otaki; Tetsu Watanabe; Yoko Shibata; Alberto Mantovani; Yasuchika Takeishi; Isao Kubota
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overload.

Authors:  Eman A Hamad; Weizhong Zhu; Tung O Chan; Valerie Myers; Erhe Gao; Xue Li; Jin Zhang; Jianliang Song; Xue-Qian Zhang; Joseph Y Cheung; Walter Koch; Arthur M Feldman
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.